Oneriver 원리버 강하나
@iamoneriver • Joined November 26, 2020
At a glance
Subscribers
Last 28 days46.8K
Views
Last 28 days2.17M
Videos
Last 28 days205
Charts
Subscribers, views & videos over time
Subscribers gained (weekly) · 6 mo
Views gained (weekly) · 6 mo
Subs milestone changes (up to 30)
Views milestone changes (up to 30)
Engagement
Avg. views per video
10.5K
Total views ÷ total videos
Views per subscriber
46×
Total views ÷ subscribers
Subs per video
228
Subscribers ÷ total videos
Revenue estimate
Details →Total (all-time): $1.52K – $4.34K
Daily avg.: $0 – $1
Weekly avg.: $2 – $5
Last 28 days: $7 – $21
Based on estimated $0.7–$2 CPM.
Analytics tables
Analytics Table:Oneriver 원리버 강하나
| Date | subscribers | views | videos |
|---|---|---|---|
Aug 3, 2026 Aug 3 Mon | 46.8K -- | 2.17M +883 | 205 +1 |
Jul 28, 2026 Jul 28 Tue | 46.8K -100 | 2.17M +940 | 204 -- |
Jul 20, 2026 Jul 20 Mon | 46.9K -- | 2.16M +5.72K | 204 +1 |
Jul 13, 2026 Jul 13 Mon | 46.9K -100 | 2.16M +3.05K | 203 -- |
Jul 12, 2026 Jul 12 Sun | 47.0K -100 | 2.16M +21.4K | 203 +1 |
Jun 18, 2026 Jun 18 Thu | 47.1K -- | 2.13M -- | 202 -- |
Subscribers gained (weekly)
| Week | Subscribers gained | Change vs prev |
|---|---|---|
Jul 12, 2026 | -101 | -100 |
Jul 13, 2026 | -101 | -- |
Jul 20, 2026 | 0 | +100 |
Jul 28, 2026 | -101 | -100 |
Aug 3, 2026 | 0 | +100 |
Views gained (weekly)
| Week | Views gained | Change vs prev |
|---|---|---|
Jul 12, 2026 | 21.4K | +21.4K |
Jul 13, 2026 | 3.05K | -18.4K |
Jul 20, 2026 | 5.72K | +2.66K |
Jul 28, 2026 | 940 | -4.78K |
Aug 3, 2026 | 883 | -57 |
About
전)증권사 제약바이오 섹터 애널리스트 서울대학교 의과대학 박사 강하나의 바이오&미용 기업/투자/금융권 탐구 한국경제바이오인사이트 객원기자 [진짜 하루만에 이해하는 제약바이오 산업] 저자 전공자가 알려주는 제약바이오/미용 알고 싶다면 구독하세요 😊 멤버쉽 가입: https://fanding.kr/@iamoneriver/membership/plan/9099/ 진짜 하루만에 이해하는 제약바이오 산업 구매: https://product.kyobobook.co.kr/detail/S000214509447 텔레그램 채널: https://t…
- Handle
- @iamoneriver
- Joined
- November 26, 2020
More features coming
We're working on new analytics and tools. Stay tuned.
More features coming
We're working on new analytics and tools. Stay tuned.